Collaborative Care Model for Type 1 Diabetes

LJ
Overseen ByLeslie Johnson, PhD, MPH
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Emory University
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 3 JurisdictionsThis treatment is already approved in other countries

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial tests a collaborative care model (CoCM) to help adults with type 1 diabetes manage their health more effectively. The study examines whether discussions with a behavioral health consultant can improve health outcomes and overall well-being. Participants will complete online surveys about their health and management habits every six months over 18 months. Adults with type 1 diabetes who speak English and have phone access are suitable candidates for this trial. As an unphased trial, it offers participants the chance to contribute to innovative research that could enhance diabetes care for many.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications.

What prior data suggests that this collaborative care model is safe for adults with type 1 diabetes?

Research has shown that the collaborative care model (CoCM) is generally safe and well-tolerated. Studies have found that this approach can improve health outcomes, such as better blood sugar control and reduced depression symptoms, without causing major side effects. In this model, healthcare professionals collaborate to support both physical and mental health, which is particularly beneficial for managing long-term conditions like type 1 diabetes.

The collaborative care model has been successfully used in primary care to help patients manage various health issues. Reports of negative effects from this model have been minimal. Instead, it focuses on enhancing overall care through teamwork and regular check-ins with healthcare providers, proving both effective and safe for participants.12345

Why are researchers excited about this trial?

Researchers are excited about the Collaborative Care Model (CoCM) for Type 1 Diabetes because it integrates behavioral health support into diabetes management. Unlike standard treatments that primarily focus on insulin therapy and routine medical care, this model offers personalized consultations with a behavioral health specialist. This approach aims to address mental health challenges, such as depression, that often accompany diabetes, potentially improving overall patient outcomes. By facilitating comprehensive care through phone or Zoom consultations, CoCM provides accessible mental health support, which is a unique addition to traditional diabetes care.

What evidence suggests that the collaborative care model is effective for type 1 diabetes?

This trial will compare the Collaborative Care Model (CoCM) with usual care for managing Type 1 Diabetes. Studies have shown that CoCM effectively manages both diabetes and depression. Research indicates that this approach improves blood sugar control by lowering HbA1c levels, an important measure of long-term blood sugar management. For people with diabetes and depression, CoCM has also improved depression symptoms. Additionally, a pharmacist-led collaborative care program has been linked to better overall blood sugar control, helping to keep blood sugar levels stable. This model involves teamwork among different healthcare providers to better support patients' mental and physical health needs.16789

Who Is on the Research Team?

LJ

Leslie Johnson, PhD, MPH

Principal Investigator

Emory University

Are You a Good Fit for This Trial?

Adults over 18 with type 1 diabetes can join this trial. It's not for those who have severe psychiatric illness, active suicidal thoughts, or don't speak English/have phone access.

Inclusion Criteria

I am an adult diagnosed with Type 1 Diabetes.

Exclusion Criteria

Individuals with the presence of severe psychiatric illness (PHQ-9โ‰ฅ20) or active suicidal ideation will also be excluded and referred to specialty care.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Intervention

Participants in the intervention group engage with a behavioral health consultant to establish personalized health goals and manage stress and healthy behaviors.

12 months
2-3 sessions per year via phone or Zoom

Follow-up

Participants are monitored for safety and effectiveness after the intervention, with assessments of HbA1c and PHQ-9 scores.

6 months
Online surveys every 6 months

What Are the Treatments Tested in This Trial?

Interventions

  • Collaborative care model (CoCM)
Trial Overview The study is comparing usual care for type 1 diabetes against a collaborative care model (CoCM) that includes regular online surveys and consultations with a behavioral health consultant.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Active Control
Group I: Collaborative care groupExperimental Treatment2 Interventions
Group II: Usual CareActive Control1 Intervention

Collaborative care model (CoCM) is already approved in United States, India, European Union for the following indications:

๐Ÿ‡บ๐Ÿ‡ธ
Approved in United States as Collaborative Care Model for:
๐Ÿ‡ฎ๐Ÿ‡ณ
Approved in India as Integrated Care Model for:
๐Ÿ‡ช๐Ÿ‡บ
Approved in European Union as Collaborative Care Model for:

Find a Clinic Near You

Who Is Running the Clinical Trial?

Emory University

Lead Sponsor

Trials
1,735
Recruited
2,605,000+

MQ Mental Health Research

Collaborator

Trials
1
Recruited
80+

Juvenile Diabetes Research Foundation

Collaborator

Trials
237
Recruited
142,000+

Published Research Related to This Trial

The Diabetes Care Collaborative Model (DCCM) was successfully implemented in 18 primary care practices, leading to significant improvements in glycemic control, with over a 1% reduction in the proportion of patients with glycated hemoglobin levels above 9% after 2 years (P < .001).
The model's success was attributed to effective teamwork, stakeholder engagement, and alignment of institutional priorities, which facilitated better insulin use among patients with hyperglycemia.
Development and Implementation of a Collaborative Team Care Model for Effective Insulin Use in an Academic Medical Center Primary Care Network.Eisenstat, SA., Chang, Y., Porneala, BC., et al.[2022]
The collaborative care management (CoCM) model can be successfully adapted for use in a low-barrier HIV clinic, which serves a complex patient population with high levels of mental illness and substance use, demonstrating its flexibility beyond traditional primary care settings.
Despite the need for significant adaptations to fit the unique context of the HIV clinic, the core structural elements of CoCM were preserved, indicating that effective behavioral health integration can be achieved even in nonconventional healthcare environments.
Adaptation of the collaborative care model to integrate behavioral health care into a low-barrier HIV clinic.Dombrowski, JC., Halliday, S., Tsui, JI., et al.[2023]
The study is evaluating the effectiveness and implementation of the Collaborative Behavioral Health Program (CBHP) in 11 primary care practices over a 30-month period, aiming to improve access to mental health services for depression.
It will provide insights into the barriers and facilitators of implementing the Collaborative Care Model (CoCM) and conduct economic analyses to assess the cost-effectiveness of the program, potentially benefiting both mental health outcomes and chronic health conditions.
Collaborative care for depression management in primary care: A randomized roll-out trial using a type 2 hybrid effectiveness-implementation design.Smith, JD., Fu, E., Rado, J., et al.[2022]

Citations

NCT06448429 | Testing an Integrated Care Model TrialThis study aims to test the use of an adapted collaborative care model for improving the health outcomes of adults diagnosed with type 1 diabetes (T1D).
Effects of Integrated Care Approaches to Address Co ...In our study we summarize the effects of IC approaches to address depression and diabetes and examine moderating effects of IC approaches (e.g., ...
Effectiveness of Collaborative Care for Depression and ...This study aimed to investigate whether CC could improve depression outcomes and HbA1c in patients with depressive symptoms and diabetes, and assess its effects ...
Cost-effectiveness of community-based integrated care ...We find that the CIC-PDD model demonstrates cost-effectiveness within primary health care settings, but further studies are needed to assess its long-term ...
The Effect of a Diabetes Collaborative Care Management ...A pharmacist-led, diabetes collaborative care management program in a patient-centered primary care setting is associated with improved glycemic control over ...
The Impact of a Collaborative Care Model on Health ...We conducted a post-hoc analysis of the INDEPENDENT trial to investigate the role of differential engagement of participants on health outcomes over 3 years.
Effects of Integrated Care on Health Outcomes in Patients ...This protocol for a systematic review and meta-analysis aims to evaluate the effects of integrated care on clinical and health outcomes in ...
Collaborative mental health care: A narrative review - PMCThe Collaborative Care model is a systematic strategy for treating behavioral health conditions in primary care through the integration of care managers and ...
Assessment of Interprofessional Collaborative Practices ...Primary care ICP was associated with reductions in HbA1c regardless of baseline levels, but the greatest reductions were found with HbA1c levels ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of ServiceยทPrivacy PolicyยทCookiesยทSecurity